Genome Medical Bridges Genomic Testing, Medical Practice
Lisa Alderson, co-founder and CEO, Genome Medical Many well-known barriers are slowing the integration of genomic testing into routine clinical practice, including workforce shortages and a lack of knowledge about genomic testing among many community-practicing primary care physicians. Genome Medical thinks it can fill in these current gaps. Genome Medical is a newly launched medical genomics practice serving both patients and physicians through an online and telemedicine-type model. Founded by some big names in the molecular testing industry, including medical geneticist Robert Green, M.D., director of the Genome2People research program at Brigham and Women’s Hospital, Broad Institute, and Harvard Medical School, and Randy Scott, Ph.D., chairman of genetic testing firm Invitae, Genome Medical has ambitious plans for growth this year. DTET recently spoke to Lisa Alderson, Genome Medical’s co-founder and CEO, to learn about the company’s business model and its role in driving awareness of genomic testing. What was the motivation for starting Genome Medical? I envision a world where genomic information is fully accessible, easily understandable, and integrated into everyday health care. We think there is a critical opportunity to help patients and health care providers use genomic information and genetic services to ultimately improve health, decrease the cost […]
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article